Absci Corporation EV/EBITDA

EV/EBITDA of ABSI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/EBITDA growth rates and interactive chart. EV/EBITDA is a ratio that compares a company’s Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation & Amortization (EBITDA). The EV/EBITDA ratio is a valuation metric used to compare the relative value of different businesses. A low EV/EBITDA compared to a stock’s historical average or industry can indicate undervaluation.

Highlights and Quick Summary

Current EV/EBITDA of Absci Corporation is 0.0 (as of December 31, 2022)
  • EV/EBITDA for the quarter ending September 30, 2023 was 0.0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly EV/EBITDA decreased by NaN%
  • Annual EV/EBITDA for 2022 was 0.0 (a NaN% decrease from previous year)
  • Annual EV/EBITDA for 2021 was 0.0 (a NaN% decrease from previous year)
  • Annual EV/EBITDA for 2020 was 0.0 (a NaN% decrease from previous year)
Visit stockrow.com/ABSI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/EBITDA of Absci Corporation

Most recent EV/EBITDAof ABSI including historical data for past 10 years.

Interactive Chart of EV/EBITDA of Absci Corporation

Absci Corporation EV/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 0.0 0.0 0.0 – –
2022 0.0 0.0 0.0 0.0 0.0
2021 0.0 0.0 0.0 0.0 0.0
2020 0.0 0.0 0.0 0.0 0.0
2019 – – – – 0.0

Business Profile of Absci Corporation

Sector: Healthcare
Industry: Biotechnology
© stockrow.com